Oddo BHF Asset Management Sas Takes $24.20 Million Position in Danaher Co. (NYSE:DHR)

Oddo BHF Asset Management Sas acquired a new position in shares of Danaher Co. (NYSE:DHR) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 87,058 shares of the conglomerate’s stock, valued at approximately $24,204,000. Danaher comprises 1.2% of Oddo BHF Asset Management Sas’ investment portfolio, making the stock its 18th largest holding.

Other institutional investors and hedge funds also recently modified their holdings of the company. Great Valley Advisor Group Inc. boosted its stake in shares of Danaher by 11.4% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 1,585 shares of the conglomerate’s stock worth $396,000 after acquiring an additional 162 shares during the period. ORG Partners LLC boosted its position in Danaher by 7,633.3% during the second quarter. ORG Partners LLC now owns 464 shares of the conglomerate’s stock worth $114,000 after purchasing an additional 458 shares during the period. Coronation Fund Managers Ltd. increased its holdings in shares of Danaher by 29.9% in the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock valued at $1,596,000 after purchasing an additional 1,470 shares during the last quarter. Blue Trust Inc. raised its position in shares of Danaher by 53.9% in the second quarter. Blue Trust Inc. now owns 8,672 shares of the conglomerate’s stock valued at $2,166,000 after purchasing an additional 3,037 shares during the period. Finally, Brookstone Capital Management lifted its stake in shares of Danaher by 23.3% during the 2nd quarter. Brookstone Capital Management now owns 10,328 shares of the conglomerate’s stock worth $2,595,000 after buying an additional 1,955 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

NYSE:DHR opened at $234.50 on Friday. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $169.37 billion, a PE ratio of 44.75, a price-to-earnings-growth ratio of 4.33 and a beta of 0.83. Danaher Co. has a twelve month low of $219.15 and a twelve month high of $281.70. The stock’s 50-day simple moving average is $247.62 and its 200 day simple moving average is $257.62.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same period in the previous year, the firm posted $2.02 EPS. The firm’s revenue was up 3.1% on a year-over-year basis. On average, analysts anticipate that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is 20.61%.

Analysts Set New Price Targets

Several research analysts have weighed in on DHR shares. TD Cowen increased their price target on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. KeyCorp increased their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Robert W. Baird reduced their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective on the stock in a research report on Thursday, October 31st. Finally, StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Thursday, December 5th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $287.95.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.